Johnson & Johnson’s COVID-19 vaccine will be a critical option for patients around the world and is the only vaccine candidate with a one-shot regimen. The new Johnson & Johnson vaccine can also be kept in a standard refrigerator, making it easier to store and administer. The Food and Drug Administration says the Johnson & Johnson vaccine has met the requirements for emergency use authorization, and several million doses could be shipped very soon to states, pharmacies and other sites, with supply ramping up quickly in April. Washington Post columnist David Ignatius interviews Johnson & Johnson CEO Alex Gorsky on Wednesday, March 3 at 9:30am.


Johnson & Johnson is partnering with Merck to make its single-shot coronavirus vaccine. CEO Alex Gorsky says the partnership is a “great example for the larger pharmaceutical industry.” “We couldn’t be more proud to be in this partnership with Merck… I think it’s also a great example for the larger pharmaceutical industry in the way we’re seeing companies partner, that we’re seeing public-private partnerships coming together, all is part of a broader effort to do everything we can to make a real difference with this virus.” (Washington Post Live)
Johnson & Johnson CEO Alex Gorsky says the company is “working with the FDA as we speak” on clinical trials to test the vaccine on children under 18, adding they’re hopeful they could have results by the time children return to school in the fall. “I would be hopeful that in that timeframe, near the end of the third quarter and into the fourth quarter that hopefully we can get that information to demonstrate safety and efficacy in adolescents and children.” (Washington Post Live)
Currently, Johnson & Johnson coronavirus vaccine is the only single-dose option on the market, but CEO Alex Gorsky says the company has started clinical trials with a second dose to see if it “could it be more durable and have a longer sustainability.” “We still have tremendous confidence in the single dose, but we’re saying, ‘Hey, what could happen if we have another dose at a later point in time?’ and we’ll have more information on that later this year.” (Washington Post Live)

Alex Gorsky

Alex Gorsky is Chairman of the Board and Chief Executive Officer of Johnson & Johnson, one of just seven leaders who have served in the dual role since the company was listed on the New York Stock Exchange in 1944.

Alex began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica in 1988. Over the next three decades, he advanced through positions of increasing responsibility in sales, marketing, and management, culminating in being named CEO and Chairman in 2012.

Under Alex’s leadership, Johnson & Johnson has both upheld the company’s 133-year legacy of delivering solutions to the world’s most urgent unmet healthcare needs, and continued to redefine expectations when it comes to purpose-driven innovation and sustainable growth on behalf of all stakeholders.

During his tenure, Johnson & Johnson has become a leading global Pharmaceutical company as well as the industry’s number one investor in research and development. The Medical Device sector is at the forefront of applying cutting-edge technology to surgery, vision care, orthopedics, and interventional solutions. And the Consumer Health business continues to evolve its portfolio of both iconic heritage brands and innovative standouts in self-care and skin health.

Outside Johnson & Johnson, Alex’s influence has shaped both the healthcare landscape and the greater business community through his work as an active member of the Business Council and the Business Roundtable. A longtime advocate of diversity and inclusion and supporter of veterans’ issues, Alex currently sits on the board of directors of the Travis Manion Foundation and IBM.

After completing his undergraduate education at the U.S. Military Academy at West Point, NY, Alex served six years in the Army. He earned his MBA from the Wharton School of the University of Pennsylvania in 1996. Alex has been married to his wife, Patricia, for more than 30 years, and they are the parents to one son, Nick.